Blood Transfusion Managed Service Contract For Betsi Cadwaladr University Health Board

Description

Betsi Cadwaladr University Health Board (BCUHB) Pathology are seeking to appoint an experienced primary Managed Service Contract provider to deliver bespoke In Vitro Diagnostics support for Transfusion services. BCUHB delivers Transfusion services for Group and Antibody screens, Cross matching, and issuing of products (via remote and electronic issue) across all 3 acute sites (Ysbyty Wrexham Maelor, Ysbyty Glan Clwyd and Ysbyty Gwynedd), with blood stocks provided on a remote/electronic issue basis to satellite services in Abergele, Denbigh, and Llandudno hospitals. The service is registered as compliant with MHRA, and shares a single unified UKAS accreditation across all 3 locations. Each acute site has a fully capable Transfusion laboratory area as part of the Blood Science laboratory and operates on a 24/7 basis as an established and resilient service model. Each site also supports theatres, cancer centres and renal units with the relevant specialist requirements. Lot 1: Betsi Cadwaladr University Health Board Pathology are seeking to appoint an experienced primary Managed Service Contract provider to deliver bespoke In Vitro Diagnostics support for Transfusion services. The Health Board is looking to hold a pre-tender supplier engagement meeting where further information on the requirement and service will be provided. This meeting will be held via Microsoft teams in the afternoon of Tuesday 19th November 2024. As part of this prior information notice, please provide your expression of interest to receive an invite to this event. Additional information: Please send any queries to nwssp.procurementcataloguepathology@wales.nhs.uk